CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,490,000 | -45.7% | 1,127,273 | 0.0% | 0.03% | -46.6% |
Q1 2022 | $10,112,000 | -20.3% | 1,127,273 | 0.0% | 0.06% | -6.5% |
Q4 2021 | $12,693,000 | -32.6% | 1,127,273 | 0.0% | 0.06% | -25.3% |
Q3 2021 | $18,825,000 | +111.9% | 1,127,273 | +181.8% | 0.08% | +112.8% |
Q2 2021 | $8,884,000 | – | 400,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |